AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022 Pharmaceutical Investing
U.S. Food and Drug Administration Approves Camzyos for the Treatment of Adults With Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP - Important Reminder for AbbVie, Inc. Investors of Securities Fraud Class Action Lawsuit Filed on their Behalf Pharmaceutical Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN Market News
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ERIC, VLTA and AUPH Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CABA, ERIC and ABBV Pharmaceutical Investing
DEADLINE ALERT for ABBV, MYPS, SDIG, LICY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VLTA, IBM and AUPH Pharmaceutical Investing
